Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
My American Story
Roads, Travel and Traffic
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
My American Story
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Dr. Reddy's Laboratories Ltd Common Stock
(NY:
RDY
)
14.38
+0.39 (+2.79%)
Official Closing Price
Updated: 4:00 PM EDT, Jul 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,176,351
Open
14.16
Bid (Size)
13.82 (100)
Ask (Size)
15.20 (7,500)
Prev. Close
13.99
Today's Range
14.16 - 14.48
52wk Range
12.19 - 15.67
Shares Outstanding
166,301,231
Dividend Yield
0.63%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Full Transcript: Dr Reddy's Laboratories Q4 2026 Earnings Call
↗
July 01, 2026
Dr Reddy's Laboratories (NYSE:RDY) released fourth-quarter financial results and hosted an earnings call on Tuesday. Read the complete transcript below. Benzinga APIs provide real-time access to...
Via
Benzinga
Topics
Earnings
Dr. Reddy’s Laboratories Limited Announces Filing of Annual Report on Form 20-F
June 26, 2026
From
Dr. Reddy’s Laboratories Limited
Via
Business Wire
Performance
YTD
+3.8%
+3.8%
1 Month
+8.4%
+8.4%
3 Month
+6.8%
+6.8%
6 Month
+2.4%
+2.4%
1 Year
-3.7%
-3.7%
More News
Read More
Dr. Reddy’s Announces the First-to-Market Launch of Bosutinib Tablets 400mg, a Generic Equivalent of Bosulif®, in the United States
June 13, 2026
From
Dr. Reddy’s Laboratories Ltd.
Via
Business Wire
Dr. Reddy's Laboratories Launches its Generic Semaglutide Injection in Canada
May 16, 2026
From
Dr. Reddy’s Laboratories Ltd.
Via
Business Wire
Dr. Reddy's Laboratories (NYSE:RDY): A Peter Lynch GARP Candidate in the Pharmaceuticals Space
↗
May 11, 2026
Via
Chartmill
Peter Lynch's GARP Strategy Identifies DR. REDDY'S LABORATORIES-ADR (NYSE:RDY) as a Candidate
↗
April 20, 2026
Via
Chartmill
DR. REDDY'S LABORATORIES-ADR (NYSE:RDY) Passes Key Peter Lynch Investment Screen
↗
March 28, 2026
Via
Chartmill
Dr. Reddy's Laboratories Q4 Earnings Call Highlights
↗
May 14, 2026
Via
MarketBeat
Topics
Earnings
Dr. Reddy's Laboratories Announces Health Canada Approval for Generic Semaglutide Injection in Canada
April 29, 2026
From
Dr. Reddy’s Laboratories Ltd.
Via
Business Wire
DR. Reddy's Laboratories (NYSE:RDY) Fits the Peter Lynch GARP Investment Strategy
↗
February 27, 2026
Via
Chartmill
Dr. Reddy’s Announces USFDA Acceptance to Review Its Biologics License Application (BLA) for Proposed Interchangeable Biosimilar, Abatacept
February 20, 2026
From
Dr. Reddy’s Laboratories Ltd.
Via
Business Wire
Dr. Reddy's Laboratories (NYSE:RDY) Passes Key Peter Lynch GARP Investment Test
↗
February 03, 2026
Via
Chartmill
Dr. Reddy's Laboratories-ADR (NYSE:RDY) Passes Peter Lynch's GARP Investment Filter
↗
January 10, 2026
Via
Chartmill
Dr. Reddy’s Announces the First-to-Market Launch of Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC), the Generic Equivalent of Extra-Strength Pataday® Once Daily Relief, in the U.S.
January 14, 2026
From
Dr. Reddy’s Laboratories Ltd.
Via
Business Wire
Dr. Reddy's Laboratories (NYSE:RDY) Passes Key Peter Lynch GARP Screens
↗
December 18, 2025
Via
Chartmill
Aurigene Oncology Limited Announces Encouraging Initial Data From 1st Two Cohorts of Phase 1 Study of AUR112, an Oral Small Molecule Inhibitor of MALT1, in Relapsed/Refractory Lymphoid Malignancies
December 02, 2025
From
Aurigene Oncology Limited
Via
Business Wire
DR. REDDY'S LABORATORIES-ADR (NYSE:RDY) Fits the Peter Lynch Investment Strategy
↗
November 26, 2025
Via
Chartmill
Dr. Reddy's Laboratories (NYSE:RDY) Fits the Peter Lynch Investment Strategy
↗
November 04, 2025
Via
Chartmill
Aurigene Oncology to Showcase Innovative A-PROX Platform at the AACR-NCI-EORTC International Conference 2025
October 22, 2025
From
Aurigene Oncology Limited
Via
Business Wire
Dr. Reddy's Laboratories-ADR (NYSE:RDY) Meets Key Peter Lynch Investment Criteria
↗
October 14, 2025
Via
Chartmill
Teva, Viatris On Investor Watch As White House Spares Generic Drugs From Tariffs
↗
October 09, 2025
Via
Benzinga
Topics
Government
World Trade
Dr. Reddy's Laboratories-ADR (NYSE:RDY) Fits the Peter Lynch GARP Strategy
↗
September 23, 2025
Via
Chartmill
Dr. Reddy's Laboratories (NYSE:RDY): A Peter Lynch-Style GARP Investment
↗
September 02, 2025
Via
Chartmill
DR. REDDY'S LABORATORIES-ADR (NYSE:RDY) Fits Peter Lynch's Growth at a Reasonable Price (GARP) Strategy
↗
August 12, 2025
Via
Chartmill
Dr. Reddy’s Reports Record Revenues in Q1, Signals Steady Execution Through Transition Year
August 04, 2025
Via
AB Newswire
Topics
Earnings
Frequently Asked Questions
Is Dr. Reddy's Laboratories Ltd Common Stock publicly traded?
Yes, Dr. Reddy's Laboratories Ltd Common Stock is publicly traded.
What exchange does Dr. Reddy's Laboratories Ltd Common Stock trade on?
Dr. Reddy's Laboratories Ltd Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Dr. Reddy's Laboratories Ltd Common Stock?
The ticker symbol for Dr. Reddy's Laboratories Ltd Common Stock is RDY on the New York Stock Exchange
What is the current price of Dr. Reddy's Laboratories Ltd Common Stock?
The current price of Dr. Reddy's Laboratories Ltd Common Stock is 14.38
When was Dr. Reddy's Laboratories Ltd Common Stock last traded?
The last trade of Dr. Reddy's Laboratories Ltd Common Stock was at 07/02/26 04:00 PM ET
What is the market capitalization of Dr. Reddy's Laboratories Ltd Common Stock?
The market capitalization of Dr. Reddy's Laboratories Ltd Common Stock is 2.39B
How many shares of Dr. Reddy's Laboratories Ltd Common Stock are outstanding?
Dr. Reddy's Laboratories Ltd Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today